Third-line treatment in metastatic renal cell carcinoma and bone metastases.
作者信息
Heng Daniel Y C
机构信息
University of Calgary, Tom Baker Cancer Center, Calgary, AB.
出版信息
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):268. doi: 10.5489/cuaj.3238.
Abstract
摘要
相似文献
1
Third-line treatment in metastatic renal cell carcinoma and bone metastases.转移性肾细胞癌和骨转移的三线治疗。
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):268. doi: 10.5489/cuaj.3238.
2
Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report.转移性肉瘤样肾细胞癌多学科治疗后的长期生存：一例报告
J Med Case Rep. 2015 Nov 19;9:261. doi: 10.1186/s13256-015-0751-0.
3
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.转移性肾细胞癌的三线靶向治疗：来自国际转移性肾细胞癌数据库联盟的结果。
Eur Urol. 2017 Feb;71(2):204-209. doi: 10.1016/j.eururo.2016.05.049. Epub 2016 Jun 16.
4
[Biological characterization of metastatic renal cell carcinoma].[转移性肾细胞癌的生物学特征]
Urologia. 2010 Jan-Mar;77 Suppl 16:37-41.
5
Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.靶向治疗转移性肾细胞癌伴脑转移患者的生存预后因素：来自国际转移性肾细胞癌数据库联盟的结果。
Clin Genitourin Cancer. 2013 Sep;11(3):311-5. doi: 10.1016/j.clgc.2013.04.012. Epub 2013 May 15.
6
Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma.血清γ-谷氨酰转移酶是转移性肾细胞癌的一个敏感但非特异性标志物。
Int J Urol. 2007 Apr;14(4):289-93. doi: 10.1111/j.1442-2042.2006.01719.x.
7
Efficacy of vertebral cryoablation and immunotherapy in a patient with metastatic renal cell carcinoma: a case report.椎体冷冻消融术与免疫疗法治疗转移性肾细胞癌 1 例疗效分析：病例报告
J Med Case Rep. 2019 Apr 21;13(1):96. doi: 10.1186/s13256-019-2049-0.
8
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.肾细胞癌转移部位的分布：一项基于人群的分析。
Ann Oncol. 2012 Apr;23(4):973-80. doi: 10.1093/annonc/mdr362. Epub 2011 Sep 2.
9
[Evaluation of bone metastases from renal cell carcinoma].[肾细胞癌骨转移的评估]
Hinyokika Kiyo. 2001 Mar;47(3):155-8.
10
[Evaluation of bone metastases from renal cell carcinoma].
Nihon Hinyokika Gakkai Zasshi. 1991 Apr;82(4):649-54. doi: 10.5980/jpnjurol1989.82.649.
本文引用的文献
1
Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma.骨转移影响转移性肾细胞癌患者的预后，但不影响三线靶向治疗的疗效。
Can Urol Assoc J. 2015 Jul-Aug;9(7-8):263-7. doi: 10.5489/cuaj.2377.
2
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy.骨转移和肝转移对接受靶向治疗的肾细胞癌患者的影响。
Eur Urol. 2014 Mar;65(3):577-84. doi: 10.1016/j.eururo.2013.08.012. Epub 2013 Aug 15.
Zotero 插件